SEC Form 4/A · accession 0001615774-16-006118
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Samuel R Saks
Director
Period of report
Jun 21, 2016
Accepted (ET)
Jun 29, 2016 · 10:20 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Jun 21, 2016 | P | 12,500 | $2.00 | A | 51,050 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The Form 4 filed on June 21, 2016 inadvertently indicated that Dr. Saks purchased 25,000 shares of common stock, when Dr. Saks actually bought $25,000 worth of stock (12,5000 shares at $2.00 each). This Amended Form 4A is being filed to correct the number of shares acquired in column 4 and to reflect the correct number of shares beneficially owned as of the date of the transaction required to be reported in column 5.